Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
PRICE T ROWE ASSOCIATES INC /MD/ FITB Fifth Third Bancorp 13G/A 4.3% 3mo
Quilvest Capital Partners SA TBBB Bbb Foods Inc 13G/A 3.5% 3mo
Bain Capital Life Sciences Opportunities III, LP KYTX Kyverna Therapeutics, Inc. 13G/A 4.75% 3mo
Key Group Long Term Investments LP BTU Peabody Energy Corp 13G/A 7% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ PRGO PERRIGO Co plc 13G/A 6.3% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC PONO Pono Capital Four, Inc. 13G 8.2% 3mo
BIOTECHNOLOGY VALUE FUND L P IVVD Invivyd, Inc. 13G/A 9.99% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ ARRY Array Technologies, Inc. 13G 5.6% 3mo
ARMISTICE CAPITAL, LLC ICCM IceCure Medical Ltd. 13G 9.99% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ KMTS Kestra Medical Technologies, Ltd. 13G/A 8.5% 3mo
Pentwater Capital Management LP CZR Caesars Entertainment, Inc. 13G 5.6% 3mo
Eric Remer EVCM EverCommerce Inc. 13G/A 7.5% 3mo
Ancient Art, L.P. UPWK Upwork, Inc 13G 6.2% 3mo
T. Rowe Price Investment Management, Inc. EGBN Eagle Bancorp Inc 13G 5.5% 3mo
T. Rowe Price Investment Management, Inc. UNIT Uniti Group Inc. 13G/A 5% 3mo
Balyasny Asset Management L.P. KRSA Korsana Biosciences, Inc. 13G 7.33% 3mo
AQR CAPITAL MANAGEMENT LLC GPAT GP-Act III Acquisition Corp. 13G/A 8.66% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC APXT Apex Treasury Corp 13G 4.6% 3mo
BRANDES INVESTMENT PARTNERS, LP UTMD Utah Medical Products Inc 13G/A 14.9% 3mo
Joseph Gebbia ABNB Airbnb, Inc. 13G/A 7.5% 3mo
Squadron Capital Management LLC CCCC C4 Therapeutics, Inc. 13G/A 6.9% 3mo
Pacific Investment Management Company LLC VG Venture Global, Inc. 13G/A 32.4% 3mo
Harraden Circle Investments, LLC MCAH Mountain Crest Acquisition 6 Corp. 13G/A 0% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ BALL BALL Corp 13G/A 4.6% 3mo
PERCEPTIVE ADVISORS LLC SABS SAB Biotherapeutics, Inc. 13G/A 7.3% 3mo
T. Rowe Price Investment Management, Inc. VLTO Veralto Corp 13G 5.6% 3mo
Ares Partners Holdco LLC AAC Ares Acquisition Corp III 13G 30.5% 3mo
Harraden Circle Investments, LLC AESP Aeon Acquisition I Corp. 13G/A 8.77% 3mo
PERCEPTIVE ADVISORS LLC SLDB Solid Biosciences Inc. 13D/A 11.2% 3mo
Point72 Asset Management, L.P. HMH HMH Holding Inc 13G/A 0% 3mo
AMERIPRISE FINANCIAL INC CRMT Americas Carmart Inc 13G 6.7% 3mo
GOLDMAN SACHS GROUP INC TRAD APEX Tech Acquisition Inc. 13G 7.6% 3mo
Kynam Capital Management, LP VRDN Viridian Therapeutics, Inc.\DE 13G/A 5.7% 3mo
T. Rowe Price Investment Management, Inc. CECO Ceco Environmental Corp 13G/A 3.7% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ THC Tenet Healthcare Corp 13G/A 9.2% 3mo
Encompass Capital Advisors LLC HMH HMH Holding Inc 13G/A 0% 3mo
David S. Rosenblatt DIBS 1stdibs.com, Inc. 13G/A 10.5% 3mo
ARMISTICE CAPITAL, LLC CLDI Calidi Biotherapeutics, Inc. 13G/A 4.99% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ UAMY United States Antimony Corp 13G 6.8% 3mo
Balyasny Asset Management L.P. XAIR Beyond Air, Inc. 13G/A 5.3% 3mo
SILVERARC CAPITAL MANAGEMENT, LLC CLRB Cellectar Biosciences, Inc. 13G 9.99% 3mo
CITADEL ADVISORS LLC PLRX Pliant Therapeutics, Inc. 13G/A 3.5% 3mo
Polar Asset Management Partners Inc. BZAI Blaize Holdings, Inc. 13G 5.6% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC SBET Sharplink, Inc. 13G 9.9% 3mo
FULLER & THALER ASSET MANAGEMENT, INC. FNB Fnb Corp 13G/A 4.69% 3mo
Caligan Partners LP AVTX Avalo Therapeutics, Inc. 13G/A 5.9% 3mo
Polar Asset Management Partners Inc. DGAC DISCIPLINED GROWTH ACQUISITION Corp 13G 8.9% 3mo
Hivemind Capital Partners, LLC UPXI Upexi, Inc. 13G/A 9.99% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC BBCQ Bleichroeder Acquisition Corp. II 13G 5.7% 3mo
RWWM, Inc. HELE Helen Of Troy Ltd 13G/A 2% 3mo